| Serial Number | 99080255 |
| Word Mark | DOPPELIB |
| Filing Date | Wednesday, March 12, 2025 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, December 3, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Product research and development services for others in the fields of proteins, antibodies, microorganisms and cells for medical use and consultancy relating thereto; Quality management services, namely, quality control in the fields of proteins, antibodies, microorganisms and cells for medical use and consultancy relating thereto; Research and development services in the field of antibody development technology; Research and development services in the field of antibody technology; Biomedical research services; Design and development of medical technology; Research and development in the field of biotechnology; Pharmaceutical research and development; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical preparations; Scientific research in the nature of conducting clinical trials for others; Technical research services, namely, conducting technical project studies in the field of antibody development technology; Technical research in the field of antibody development technology; Engineering services, particularly technical project planning in the field of antibody development technology; Research and development of new products for others; Design and development of computer software for use with medical technology; Software design and development; Rental of computer software for use with medical technology; Providing temporary use of on-line non-downloadable software for use with medical technology; Providing virtual computer systems through cloud computing; Scientific laboratory services relating to the acquisition, isolation and cultivation of antibodies, namely, antibodies or antibody-producing cells with desired properties from a population of cells that produce various antibodies; Scientific laboratory services relating to the screening, isolation and cultivation of antibodies, namely, antibodies or antibody-producing cells with desired properties from a population of cells that produce various antibodies, or the acquisition of antibodies or antibody-producing cells with desired properties; Provision of cell lines for scientific and medical research and development; Provision of antibodies for scientific and medical research and development |
| Goods and Services | Biomanufacturing for others, namely, contract-based purification of antibodies; Biomanufacturing for others, namely, selection and purification of antibodies; Biomanufacturing for others, namely, selection and purification of proteins; Custom manufacturing of cell lines for laboratory, research and development, or medical purposes; Custom manufacturing of cell lines for antibody production; Custom manufacturing of cell lines; Biomanufacturing for others, namely, biomanufacturing of biological cultured tissues for medical, laboratory, or research and development purposes; Biomanufacturing for others, namely, biomanufacturing of biological cultured tissues; Biomanufacturing for others, namely, contract-based biomanufacturing of biological preparations in the nature of proteins; Processing of biological pharmaceutical preparations for others; Treatment of biological pharmaceutical preparations for others; Biomanufacturing for others, namely, selection and purification of biological preparations in the nature of proteins; Contract-based biomanufacturing in the field of pharmaceuticals; Biomanufacturing for others, namely, selection and purification of pharmaceuticals; Biomanufacturing for others, namely, selection and purification of pharmaceutical preparations; Cryogenic preservation of biological tissues; Custom manufacturing of dietary supplements for humans; Food processing; Dietetic food and drink processing; Preservation of antibodies for scientific and medical research and development |
| Pseudo Mark | DOPPE LIB |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 12, 2025 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 12, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CHIOME BIOSCIENCE INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Tokyo 1510071 JP |
| Event Date | Event Description |
| Wednesday, March 12, 2025 | NEW APPLICATION ENTERED |
| Wednesday, March 12, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, July 10, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, August 13, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, September 3, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 3, 2025 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 3, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, December 3, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, December 3, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, December 3, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 4, 2025 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Thursday, December 4, 2025 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |